Outcome of patients with HER2-positive advanced breast cancer progressing during trastuzumab-based therapy.

@article{Montemurro2006OutcomeOP,
  title={Outcome of patients with HER2-positive advanced breast cancer progressing during trastuzumab-based therapy.},
  author={Filippo Montemurro and Michela Donadio and Matteo Clavarezza and Stefania Redana and Maria Elena Jacomuzzi and Giorgio Valabrega and Saverio Danese and Guido Vietti-Ramus and Antonio Durando and Marco Venturini and Massimo Aglietta},
  journal={The oncologist},
  year={2006},
  volume={11 4},
  pages={318-24}
}
We sought to describe patterns of treatment and clinical outcome in patients with HER2-positive advanced breast cancer progressing on trastuzumab-based therapy. One hundred eighty-four consecutive HER2-positive advanced breast cancer patients received trastuzumab-based therapy between September 1999 and September 2004. Patients were followed up until death or May 2005. For patients progressing on trastuzumab-based therapy, we calculated the response rate (RR) to the first post-progression… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 57 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 21 references

Similar Papers

Loading similar papers…